RHYTHM

📅 Upcoming

🕒 Recent(90d)

News

• Abbott garners FDA nod for its TactiFlex catheter to treat AFib
  Abbot received FDA clearance for its latest-generation catheter that allows physicians more flexibility when treating atrial fibrillation in patients.
  fiercebiotech · 2d ago
• FDA Grants Accelerated Approval to a New Breast Cancer Treatment
  The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting ne…
  fda_press · 7d ago
• An AI drug specialist zeroes in on rare forms of obesity
  Superluminal Medicines banked $60 million in funding to support development of a drug designed to work similarly to — but potentially be more selectively than — Rhythm Pharmaceuticals’ marketed med…
  biopharma_dive · 8d ago
• Superluminal secures $60M for Phase 1 of genetic obesity drug
  A Boston biotech following in the footsteps of Rhythm Pharmaceuticals and others in the MC4R obesity field has raised $60 million to test its approach in Phase 1. Superluminal Medicines secured the…
  endpoints · 8d ago
• Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
  FOR IMMEDIATE RELEASE - August 27, 2026 - Davie, Florida – Ana Salazar Modela Tu Cuerpo Inc. is recalling Lipofit Extreme Fat Burner 2.0, Lot 25M12F, expiration date 09/2027, to the consumer level.…
  fda_recalls · 15d ago
• Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
  Vivace Therapeutics has named Craig Gibbs, Ph.D., as its new president and CEO.
  fiercebiotech · 15d ago
• Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns
  Vitruvias Therapeutics has “ceased operations” after voluntarily recalling a batch recall of generic thyroid tablets due to possible superpotency that could cause a range of adverse events.
  biospace · 16d ago
• Opinion: Whale songs: the sounds of love and loss as heard by an OB-GYN
  “I have developed a trained ear for many kinds of ‘humanized’ whale songs especially the types sung by women,” writes physician Caroline Cherston.
  stat · 17d ago
• Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
  AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics, Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled b…
  fda_medwatch · 18d ago
• ‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it
  As the hype around the vast medical potential of GLP-1 drugs continues unabated, another peptide is starting to make its own mark.
  fiercebiotech · 21d ago